NDC 55289-920-90
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-90
- Package NDCs from labels
- 55289-920-90
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | a1f8be75-2eb9-4eef-8fb4-144ef2bf7ae1 | 2026-02-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Cyproheptadine Hydrochloride | CYPROHEPTADINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 03e69414-8a25-4ed8-b7ac-16445b879b1f | 2026-02-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 12c8da39-3a0e-4303-9655-29dd83507837 | 2026-02-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| GABAPENTIN | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 9814b76c-87c6-4746-b712-3269352a901b | 2026-02-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| AZATHIOPRINE | AZATHIOPRINE | PD-Rx Pharmaceuticals, Inc. | d288e484-32fc-4b46-b504-d75a0fac8663 | 2026-02-16 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | f60b0690-aca9-40ec-956e-bd2ecc35ec54 | 2026-02-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | f229e8b4-7045-4c0d-9214-890c0bda3c2a | 2026-02-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9d0608a1-0cc8-491a-ad91-238e0ea009fe | 2026-02-16 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| LOSARTAN POTASSIUM 25 mg | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 372ba4ad-26ca-4675-8475-4b664fbecba9 | 2026-02-16 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| MELOXICAM | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 19c13159-71f1-2427-e063-6394a90ad44e | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Alprazolam | ALPRAZOLAM | A-S Medication Solutions | 8ef75d22-4a7c-48d5-a532-5a43b8593e7c | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | Alprazolam ALPRAZOLAM |
| CYCLOBENZAPRINE HYDROCHLORIDE | CYCLOBENZAPRINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 4eaa675a-c24c-4043-8fdf-9d59e5e4f4d5 | 2026-01-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | f543f5d1-3348-4066-99a4-7a00aee1530d | 2026-01-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | 15d0a711-ef3b-4d93-8fbc-17a45f96af8a | 2026-01-20 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ondansetron | ONDANSETRON | PD-Rx Pharmaceuticals, Inc. | d117de5f-64e5-464c-b782-de0f07e66c8e | 2026-01-20 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Carvedilol | CARVEDILOL | PD-Rx Pharmaceuticals, Inc. | 444ee05c-571a-4ea6-8763-af05d252df56 | 2026-01-20 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 64650d2c-2bec-4470-b250-29d01caa1ebe | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | PD-Rx Pharmaceuticals, Inc. | 18f44ba2-d431-4a73-ac78-83e734fde694 | 2026-01-16 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Alprazolam | ALPRAZOLAM | Natco Pharma USA LLC | b3c55877-2538-4892-bdb1-d618c643d29c | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | Alprazolam ALPRAZOLAM |
| Metoprolol Succinate | METOPROLOL SUCCINATE | PD-Rx Pharmaceuticals, Inc. | ff3eaf6a-5697-4ad9-98c4-86925e6da257 | 2026-01-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.